Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 12-2018 | 05-2016 | |
| Sales | 0 | 0 | 0 | 0 | 1,415 |
| Cost of Goods | N/A | N/A | N/A | N/A | 538 |
| Gross Profit | N/A | N/A | N/A | N/A | 877 |
| Operating Expenses | 35,156 | 37,702 | 0 | 0 | 3,656 |
| Operating Income | -35,156 | -37,702 | N/A | N/A | -2,241 |
| Interest Expense | 0 | 0 | 0 | 0 | 2 |
| Other Income | 8,423 | -15,506 | 0 | 0 | 738 |
| Pre-tax Income | -26,733 | -53,208 | 0 | 0 | -1,505 |
| Income Tax | -16 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -26,717 | -53,208 | N/A | N/A | -1,505 |
| Net Income | $-26,717 | $-53,208 | $N/A | $N/A | $-1,505 |
| EPS Basic Total Ops | -0.44 | -0.87 | N/A | N/A | -0.08 |
| EPS Basic Continuous Ops | -0.44 | -0.87 | N/A | N/A | -0.08 |
| EPS Diluted Total Ops | -0.44 | -0.87 | N/A | N/A | -0.08 |
| EPS Diluted Continuous Ops | -0.44 | -0.87 | N/A | N/A | -0.08 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | N/A | -0.08 |
| EBITDA(a) | $-34,966 | $-37,607 | $N/A | $N/A | $-2,146 |